March 27, 2017
Amryt finds new CCO in Aegerion Pharmaceuticals after former one leaves
Amryt, the pharmaceutical company focused on treatments for rare and orphan diseases, has appointed David Allmond as Chief Commercial Officer in a non-board capacity, with effect from 3 April 2017.